Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature

by Ge, Jennifer Y., Overmoyer, Beth
Published in Case Rep Oncol (2021)

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study

by Jagsi, Reshma, Griffith, Kent A., Bellon, Jennifer R., Woodward, Wendy A., Horton, Janet K., Ho, Alice, Feng, Felix Y., Speers, Corey, Overmoyer, Beth, Sabel, Michael, Schott, Anne F., Pierce, Lori
Published in J Clin Oncol (2018)

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

by Golshan, Mehra, Cirrincione, Constance T., Sikov, William M., Carey, Lisa A., Berry, Donald A., Overmoyer, Beth, Henry, Nora L., Somlo, George, Port, Elisa, Burstein, Harold J., Hudis, Clifford, Winer, Eric, Ollila, David W.
Published in Breast Cancer Res Treat (2016)

Prospective clinical experience with research biopsies in breast cancer patients

by Vaz-Luis, Ines, Zeghibe, Catherine A., Frank, Elizabeth S., Sohl, Jessica, Washington, Kimberly E., Silverman, Stuart G., Fonte, Joseph M., Mayer, Erica L., Overmoyer, Beth A., Richardson, Andrea L., Krop, Ian E., Winer, Eric P., Lin, Nancy U.
Published 2013

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer

by Tolaney, Sara M., Tan, Sally, Guo, Hao, Barry, William, Van Allen, Eliezer, Wagle, Nikhil, Brock, Jane, Larrabee, Katherine, Paweletz, Cloud, Ivanova, Elena, Janne, Pasi, Overmoyer, Beth, Wright, John J., Shapiro, Geoffrey I., Winer, Eric P., Krop, Ian E.
Published in Invest New Drugs (2015)

A Vasculature-Targeting Regimen of Pre-Operative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers

by Baar, Joseph, Silverman, Paula, Lyons, Janice, Fu, Pingfu, Abdul-Karim, Fadi, Ziats, Nicholas, Wasman, Jay, Hartman, Paul, Jesberger, John, Dumadag, Leda, Hohler, Erin, Leeming, Rosemary, Shenk, Robert, Chen, Helen, McCrae, Keith, Dowlati, Afshin, Remick, Scot C., Overmoyer, Beth
Published 2009

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine

by Krishnamurthi, Smitha S., Brell, Joanna M., Hoppel, Charles L., Egorin, Merrill J., Weaver, Karen C., Li, Xiaolin, Ingalls, Stephen T., Zuhowski, Eleanor G., Schluchter, Mark D., Dowlati, Afshin, Cooney, Matthew M., Gibbons, Joseph, Overmoyer, Beth A., Ivy, S. Percy, Remick, Scot C.
Published in Cancer Chemother Pharmacol (2008)

Kinetic-Pharmacodynamic Model of Chemotherapy Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel or Ixabepilone: CALGB...

by Mehrotra, Shailly, Sharma, Manish R., Gray, Elizabeth, Wu, Kehua, Barry, William T., Hudis, Clifford, Winer, Eric P., Lyss, Alan P., Toppmeyer, Deborah L., Moreno-Aspitia, Alvaro, Lad, Thomas E., Valasco, Mario, Overmoyer, Beth, Rugo, Hope, Ratain, Mark J., Gobburu, Jogarao V.
Published in AAPS J (2017)

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

by Sharma, Manish R., Mehrotra, Shailly, Gray, Elizabeth, Wu, Kehua, Barry, William T., Hudis, Clifford, Winer, Eric P., Lyss, Alan P., Toppmeyer, Deborah L., Moreno-Aspitia, Alvaro, Lad, Thomas E., Velasco, Mario, Overmoyer, Beth, Rugo, Hope S., Ratain, Mark J., Gobburu, Jogarao V.
Published in J Clin Pharmacol (2019)

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

by Stover, Daniel G., Gil Del Alcazar, Carlos R., Brock, Jane, Guo, Hao, Overmoyer, Beth, Balko, Justin, Xu, Qiong, Bardia, Aditya, Tolaney, Sara M., Gelman, Rebecca, Lloyd, Maxwell, Wang, Yu, Xu, Yaomin, Michor, Franziska, Wang, Vivian, Winer, Eric P., Polyak, Kornelia, Lin, Nancy U.
Published in NPJ Breast Cancer (2018)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

by Rashkin, Sara R., Chua, Katherina C., Ho, Carol, Mulkey, Flora, Jiang, Chen, Mushiroda, Tasei, Kubo, Michiaki, Friedman, Paula N., Rugo, Hope S., McLeod, Howard L., Ratain, Mark J., Castillos, Francisco, Naughton, Michael, Overmoyer, Beth, Toppmeyer, Deborah, Witte, John S., Owzar, Kouros, Kroetz, Deanna L.
Published in Clin Pharmacol Ther (2018)

Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients

by Tolaney, Sara M., Ziehr, David R., Guo, Hao, Ng, Mei R., Barry, William T., Higgins, Michaela J., Isakoff, Steven J., Brock, Jane E., Ivanova, Elena V., Paweletz, Cloud P., Demeo, Michelle K., Ramaiya, Nikhil H., Overmoyer, Beth A., Jain, Rakesh K., Winer, Eric P., Duda, Dan G.
Published in Oncologist (2017)

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

by Tolaney, Sara M., Barry, William T., Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Matthew, Shapira, Iuliana, Wolff, Antonio C., Carey, Lisa A., Overmoyer, Beth A., Partridge, Ann H., Guo, Hao, Hudis, Clifford A., Krop, Ian E., Burstein, Harold J., Winer, Eric P.
Published in N Engl J Med (2015)

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Cli...

by Tolaney, Sara M., Barroso-Sousa, Romualdo, Keenan, Tanya, Li, Tianyu, Trippa, Lorenzo, Vaz-Luis, Ines, Wulf, Gerburg, Spring, Laura, Sinclair, Natalie Faye, Andrews, Chelsea, Pittenger, Jessica, Richardson, Edward T., Dillon, Deborah, Lin, Nancy U., Overmoyer, Beth, Partridge, Ann H., Van Allen, Eliezer, Mittendorf, Elizabeth A., Winer, Eric P., Krop, Ian E.
Published in JAMA Oncol (2020)

Chemotherapy-Related Amenorrhea after Adjuvant Paclitaxel-Trastuzumab (APT Trial)

by Ruddy, Kathryn J., Guo, Hao, Barry, William, Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Matthew J., Shapira, Iuliana, Wolff, Antonio C., Carey, Lisa A., Overmoyer, Beth A., Hudis, Clifford, Krop, Ian E., Burstein, Harold J., Winer, Eric P., Partridge, Ann H., Tolaney, Sara M.
Published in Breast Cancer Res Treat (2015)

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

by Ueno, Naoto T., Espinosa Fernandez, Jose Rodrigo, Cristofanilli, Massimo, Overmoyer, Beth, Rea, Dan, Berdichevski, Fedor, El-Shinawi, Mohamad, Bellon, Jennifer, Le-Petross, Huong T., Lucci, Anthony, Babiera, Gildy, DeSnyder, Sarah M., Teshome, Mediget, Chang, Edward, Lim, Bora, Krishnamurthy, Savitri, Stauder, Michael C, Parmar, Simrit, Mohamed, Mona M, Alexander, Angela, Valero, Vicente, Woodward, Wendy A.
Published in J Cancer (2018)

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10(th) Anniversary Conference

by Woodward, Wendy A., Cristofanilli, Massimo, Merajver, Sofia D., Van Laere, Steven, Pusztai, Lajos, Bertucci, Francois, Berditchevski, Fedor, Polyak, Kornelia, Overmoyer, Beth, Devi, Gayathri R., Sterneck, Esta, Schneider, Robert, Debeb, Bisrat G., Wang, Xiaoping, van Golen, Kenneth L., El-Zein, Randa, Rahal, Omar M., Alexander, Angela, Reuben, James M., Krishnamurthy, Savitri, Lucci, Anthony, Ueno, Naoto T.
Published in J Cancer (2017)

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium

by Devi, Gayathri R., Hough, Holly, Barrett, Nadine, Cristofanilli, Massimo, Overmoyer, Beth, Spector, Neil, Ueno, Naoto T., Woodward, Wendy, Kirkpatrick, John, Vincent, Benjamin, Williams, Kevin P., Finley, Charlotte, Duff, Brandi, Worthy, Valarie, McCall, Shannon, Hollister, Beth A., Palmer, Greg, Force, Jeremy, Westbrook, Kelly, Fayanju, Oluwadamilola, Suneja, Gita, Dent, Susan F., Hwang, E. Shelley, Patierno, Steven R., Marcom, P. Kelly
Published in J Cancer (2019)

Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC)

by Keenan, Tanya E., Li, Tianyu, Vallius, Tuulia, Guerriero, Jennifer L., Tayob, Nabihah, Kochupurakkal, Bose, Davis, Janae, Pastorello, Ricardo, Tahara, Rie K., Anderson, Leilani, Conway, Jake, He, Meng X., Shannon, Erin, Godin, Robert E., Sorger, Peter K., D’Andrea, Alan, Overmoyer, Beth, Winer, Eric P., Mittendorf, Elizabeth A., Van Allen, Eliezer M., Shapiro, Geoffrey I., Tolaney, Sara M.
Published in Clin Cancer Res (2020)

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

by Tolaney, Sara M., Guo, Hao, Pernas, Sonia, Barry, William T., Dillon, Deborah A., Ritterhouse, Lauren, Schneider, Bryan P., Shen, Fei, Fuhrman, Kit, Baltay, Michele, Dang, Chau T., Yardley, Denise A., Moy, Beverly, Marcom, P. Kelly, Albain, Kathy S., Rugo, Hope S., Ellis, Mathew J., Shapira, Iuliana, Wolff, Antonio C., Carey, Lisa A., Overmoyer, Beth, Partridge, Ann H., Hudis, Clifford A., Krop, Ian E., Burstein, Harold J., Winer, Eric P.
Published in J Clin Oncol (2019)